Effects of two combined oral contraceptives containing ethinyl estradiol 30 mu g combined with either gestodene or drospirenone on hemostatic parameters, lipid profiles and blood pressure

Yildizhan R., YILDIZHAN B., Adali E., Yoruk P., Birol F., Suer N.

ARCHIVES OF GYNECOLOGY AND OBSTETRICS, cilt.280, sa.2, ss.255-261, 2009 (SCI-Expanded) identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 280 Sayı: 2
  • Basım Tarihi: 2009
  • Doi Numarası: 10.1007/s00404-008-0907-x
  • Dergi Adı: ARCHIVES OF GYNECOLOGY AND OBSTETRICS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.255-261
  • Anahtar Kelimeler: Oral contraceptives, Ethinylestradiol, Drospirenone, Gestodene, RENIN-ALDOSTERONE SYSTEM, CYCLE CONTROL, CARBOHYDRATE-METABOLISM, PROGESTIN DROSPIRENONE, OPEN-LABEL, DESOGESTREL, ETHINYLESTRADIOL, EFFICACY, LIPOPROTEIN, TOLERANCE
  • Marmara Üniversitesi Adresli: Evet

Özet

The aim of this study is to compare the effect of ethinyl estradiol 0.03 mg/gestodene 0.075 mg (EE/GSD) with ethinylestradiol 0.03 mg/drospirenone 3 mg (EE/DRSP) administered according to conventional 21/7 regimen on body mass index (BMI), blood pressure (BP), lipid metabolism and hemostatic parameters.